Cathelicidin‐related antimicrobial peptide protects against ischaemia reperfusion‐induced acute kidney injury in mice
British Journal of Pharmacology2020Vol. 177(12), pp. 2726–2742
Citations Over TimeTop 10% of 2020 papers
Li‐Long Pan, Wenjie Liang, Zhengnan Ren, Chunqing Li, Yong Chen, Wenying Niu, Xin Fang, Yanyan Liu, Ming Zhang, James S. Diana, Birgitta Agerberth, Jia Sun
Abstract
Our results suggest that CRAMP acts as a novel immunomodulatory mediator of AKI and modulation of CRAMP may represent a potential therapeutic strategy.
Related Papers
- → Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes(2020)68 cited
- → Cathelicidin Mediates a Protective Role of Vitamin D in Ulcerative Colitis and Human Colonic Epithelial Cells(2020)49 cited
- → Chronic-on-acute kidney injury(2012)25 cited
- → Antibacterial Function of the Human Cathelicidin-18 Peptide (LL-37) between Theory and Practice(2014)8 cited
- [Prevalence of chronic kidney disease].(2009)